Director, Companion Diagnostics Strategy Lead

California, United States
Jul 24, 2021
Required Education
Position Type
Full time
About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

AbbVie is offering a unique opportunity for a highly motivated individual to join our team as a Director, Companion Diagnostics Strategy Lead within the Precision Medicine Companion Diagnostics team, which supports CDx development across therapeutic areas (oncology/immunology/neuroscience). We are seeking a creative and highly motivated leader to develop and implement global diagnostic strategies to enable and support the global development and commercialization of medically differentiated therapies. The successful candidate will have the opportunity to work in a highly collaborative environment and will be a key member of multidisciplinary development project teams.

Essential Duties and Job Functions:

  • Responsible for the overarching global CDx strategy across projects in targeted therapeutic areas
  • Lead the development and implementation of diagnostic strategies for individual projects and/or therapeutic areas
  • Direct the development, outsourcing and validation of clinically applicable companion diagnostic assays for FIH and registrational studies
  • Design, implement and oversee diagnostic testing and data analysis
  • Provide expertise to development project teams to ensure access to state of the art thinking on appropriate diagnostic technologies, evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to the proposed companion diagnostic assay
  • Lead joint development teams between AbbVie and Dx partners to ensure co-development timelines are met
  • Expertise in biomarker testing technologies (immunohistochemistry, FISH, NGS, PCR, flowcytometry, etc)
  • Experience in leading interactions with global health authorities regarding companion diagnostics development and submissions


Desired Skills and Experience:

  • Highly experienced biomedical leader (PhD or MD/PhD) with a minimum of 10 years of post-doctoral and relevant industry experience with expertise in oncology/immunology/neuroscience biomarker and/or companion diagnostic development
  • Demonstrated excellence in developing and implementing overarching therapeutic area CDx strategies
  • Demonstrated excellence in independently leading and conducting research and ability to evaluate, interpret and present complex scientific data
  • Experience in human translational research with biomarker application in clinical trials and awareness of the challenges of implementing diagnostic technologies in the clinical setting
  • Excellent leadership skills including motivation and delegation
  • Excellent verbal and written communication and presentation skills in English
  • High level of initiative and ability to work independently
  • High level of business awareness

Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Yes, 10 % of the Time
Job Type
Job Level Code
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.